Publicaciones en las que colabora con Andres Iñiguez Romo (11)

2024

  1. Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial

    Revista Espanola de Cardiologia, Vol. 77, Núm. 3, pp. 215-225

2023

  1. Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND study

    American Heart Journal, Vol. 264, pp. 72-82

2022

  1. Cierre de orejuela izquierda frente a ACOD en pacientes mayores: análisis con emparejamiento por puntuación de propensión

    REC: Interventional Cardiology, Vol. 4, Núm. 4, pp. 304-310

2021

  1. 10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction

    Journal of the American College of Cardiology, Vol. 77, Núm. 9, pp. 1165-1178

  2. Impact of Comorbidities and Antiplatelet Regimen on Platelet Reactivity Levels in Patients Undergoing Transcatheter Aortic Valve Implantation

    Journal of cardiovascular pharmacology, Vol. 78, Núm. 3, pp. 463-473

  3. Pacemaker lead implantation in a patient with transcatheter bicaval prosthesis

    Europace

2020

  1. Influence of Valve Type and Antiplatelet Regimen on Platelet Reactivity After TAVI: Subanalysis of the REAC-TAVI Trial

    The Journal of invasive cardiology, Vol. 32, Núm. 12, pp. 446-452

2019

  1. Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement: The REAC-TAVI Trial

    JACC: Cardiovascular Interventions, Vol. 12, Núm. 1, pp. 22-32

2017

  1. Acute myocardial infarction due to left main embolization of calcified tissue from mitral valve subapparatus

    Journal of Cardiology Cases, Vol. 15, Núm. 6, pp. 194-196

2016

  1. A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy

    Cardiovascular Revascularization Medicine, Vol. 17, Núm. 6, pp. 355-361

2014

  1. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: Results from the Metocard-CNIC trial (Effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction)

    Journal of the American College of Cardiology, Vol. 63, Núm. 22, pp. 2356-2362